ARTICLE | Company News

Targeted Molecular Diagnostics LLC, University of Texas M.D. Anderson Cancer Center deal

June 28, 2004 7:00 AM UTC

Targeted Molecular and the center partnered to study expression levels of cyclin E in tumor tissues from colon cancer patients who have had liver metastases. The goal is to predict whether a patient i...